|
Volumn 43, Issue 2, 2002, Pages 275-280
|
Therapy-related acute myeloid leukemia and myelodysplasia after successful treatment of acute promyelocytic leukemia
a a
a
HÔTEL DIEU
(France)
|
Author keywords
Acute promyelocytic leukemia; Low dose methotrexate; Therapy related acute myeloide leukemia; Therapy related myelodysplastic syndrome
|
Indexed keywords
ACLARUBICIN;
ALKYLATING AGENT;
ANTHRACYCLINE;
BUSULFAN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
DOXORUBICIN;
ETOPOSIDE;
IDARUBICIN;
MERCAPTOPURINE;
METHOTREXATE;
MITOXANTRONE;
RETINOIC ACID;
TIOGUANINE;
ACUTE GRANULOCYTIC LEUKEMIA;
ADULT;
ARTICLE;
AUTOLOGOUS BONE MARROW TRANSPLANTATION;
CANCER INCIDENCE;
CANCER RISK;
CANCER SURVIVAL;
CHROMOSOME 21Q;
CHROMOSOME 5;
CHROMOSOME 7;
CHROMOSOME ABERRATION;
CHROMOSOME DELETION;
CHROMOSOME DELETION 5;
CHROMOSOME DELETION 7;
CHROMOSOME LOSS;
CHROMOSOME TRANSLOCATION 21;
CLINICAL ARTICLE;
CONTROLLED STUDY;
FEMALE;
HUMAN;
LATENT PERIOD;
LEUKEMIA REMISSION;
MALE;
MYELODYSPLASIA;
PRIORITY JOURNAL;
PROGNOSIS;
PROMYELOCYTIC LEUKEMIA;
SURVIVAL TIME;
ACUTE DISEASE;
ANTINEOPLASTIC AGENTS;
CHROMOSOME ABERRATIONS;
HUMANS;
LEUKEMIA, MYELOID;
LEUKEMIA, PROMYELOCYTIC, ACUTE;
MYELODYSPLASTIC SYNDROMES;
NEOPLASMS, SECOND PRIMARY;
|
EID: 0036192384
PISSN: 10428194
EISSN: None
Source Type: Journal
DOI: 10.1080/10428190290006044 Document Type: Article |
Times cited : (27)
|
References (29)
|